Hypoxia-inducible factor (HIF) in hormone signaling during health and disease

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 11, Issue 2, 2013, Pages 125-135

  Dehne, Nathalie ^a   Fuhrmann, Dominik ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cancer; Hypoxia inducible factor; Insulin; Insulin like growth factor; Interferon; Interleukin; mTOR; Tumor necrosis factor; Vascular endothelial growth factor

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL) IMIDAZO [4, 5 C] QUINOLIN 2 (1H, 3H) ONE; 1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; CHEMOKINE RECEPTOR CXCR; CYTOKINE RECEPTOR; E1A ASSOCIATED P300 PROTEIN; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; LIFICIGUAT; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; OLIGOMYCIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN TYROSINE KINASE; SMAD PROTEIN; SOMATOMEDIN; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; DNA DEGRADATION; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; INTRACELLULAR SIGNALING; NEOPLASM; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA TRANSLATION; TUMOR GROWTH;

DISEASE; GENE EXPRESSION REGULATION; HEALTH; HORMONES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOTRANSFERASES; SIGNAL TRANSDUCTION;

EID: 84878661871     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/1871525711311020008     Document Type: Article

References (122)

1. Wang, G.L.; Semenza, G.L. General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA, 1993, 90(9), 4304-4308.
2. Zhou, J.; Brune, B. Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha), Cardiovasc. Hematol. Agents Med. Chem., 2006, 4(3), 189-197.
3. Kaelin, W.G., Jr.; Ratcliffe, P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway, Mol. Cell, 2008, 30(4), 393-402.
4. Brune, B.; Dehne, N. Sensors, transmitters and targets in mitochondrial oxygen shortage-a HIF relay story. Antioxid. Redox. Signal., 2012, in press.
5. Schodel, J.; Oikonomopoulos, S.; Ragoussis, J.; Pugh, C.W.; Ratcliffe, P.J.; Mole, D.R. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood, 2011, 117(23), e207-217.
6. Xia, X.; Lemieux, M.E.; Li, W.; Carroll, J.S.; Brown, M.; Liu, X.S.; Kung, A.L. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. USA, 2009, 106(11), 4260-4265.
7. Lisy, K.; Peet, D.J. Turn me on: regulating HIF transcriptional activity. Cell Death Differ., 2008, 15(4), 642-649.
8. Hewitson, K.S.; Lienard, B.M.; McDonough, M.A.; Clifton, I.J.; Butler, D.; Soares, A.S.; Oldham, N.J.; McNeill, L.A.; Schofield, C.J. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem., 2007, 282(5), 3293-3301.
9. Lu, H.; Dalgard, C.; Mohyeldin, A.; McFate, T.; Tait, A.S.; Verma, A.; Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem., 2005, 280(51), 41928-41939.
10. Koivunen, P.; Hirsila, M.; Remes, A.M.; Hassinen, I.E.; Kivirikko, K.I.; Myllyharju, J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem., 2007, 282(7), 4524-4532.
11. Matsumoto, K.; Imagawa, S.; Obara, N.; Suzuki, N.; Takahashi, S.; Nagasawa, T.; Yamamoto, M. 2-oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1alpha and inhibits angiogenesis. J. Cell Physiol., 2006, 209(2), 333-340.
12. Kwon, S.J.; Lee, Y.J. Effect of low glutamine/glucose on hypoxiainduced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin. Cancer Res., 2005, 11(13), 4694-4700.
13. Malhotra, R.; Tyson, D.G.; Sone, H.; Aoki, K.; Kumagai, A.K.; Brosius, F.C. 3rd. Glucose uptake and adenoviral mediated GLUT1 infection decrease hypoxia-induced HIF-1alpha levels in cardiac myocytes. J. Mol. Cell Cardiol., 2002, 34(8), 1063-1073.
14. Catrina, S.B.; Okamoto, K.; Pereira, T.; Brismar, K.; Poellinger, L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes, 2004, 53(12), 3226-3232.
15. Gao, W.; Ferguson, G.; Connell, P.; Walshe, T.; Murphy, R.; Birney, Y.A.; O'Brien, C.; Cahill, P.A. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J. Mol. Cell. Cardiol., 2007, 42(3), 609-619.
16. Dehne, N.; Hintereder, G.; Brune, B. High glucose concentrations attenuate hypoxia-inducible factor-1alpha expression and signaling in non-tumor cells. Exp. Cell Res., 2010, 316(7), 1179-1189.
17. Berchner-Pfannschmidt, U.; Yamac, H.; Trinidad, B.; Fandrey, J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J. Biol. Chem., 2007, 282(3), 1788-1796.
18. Knaup, K.X.; Jozefowski, K.; Schmidt, R.; Bernhardt, W.M.; Weidemann, A.; Juergensen, J.S.; Warnecke, C.; Eckardt, K.U.; Wiesener, M.S. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Mol. Cancer Res., 2009, 7(1), 88-98.
19. Bian, C.X.; Shi, Z.; Meng, Q.; Jiang, Y.; Liu, L.Z.; Jiang, B.H. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression. Biochem. Biophys. Res. Commun., 2010, 398(3), 395-399.
20. Young, R.M.; Wang, S.J.; Gordan, J.D.; Ji, X.; Liebhaber, S.A.; Simon, M.C. Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J. Biol. Chem., 2008, 283(24), 16309-16319.
21. Lang, K.J.; Kappel, A.; Goodall, G.J. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia, Mol. Biol. Cell., 2002, 13(5), 1792-1801.
22. Toschi, A.; Lee, E.; Gadir, N.; Ohh, M.; Foster, D.A. Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J. Biol. Chem., 2008, 283(50), 34495-34499.
23. Dinarello, C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood, 2011, 117(14), 3720-3732.
24. Sharma, V.; Dixit, D.; Koul, N.; Mehta, V.S.; Sen, E. Ras regulates interleukin-1beta-induced HIF-1alpha transcriptional activity in glioblastoma. J. Mol. Med. (Berl.)., 2011, 89(2), 123-136.
25. Frede, S.; Freitag, P.; Otto, T.; Heilmaier, C.; Fandrey, J.; The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation, Cancer Res., 2005, 65(11), 4690-4697.
26. Mori, A.; Moser, C.; Lang, S.A.; Hackl, C.; Gottfried, E.; Kreutz, M.; Schlitt, H.J.; Geissler, E.K.; Stoeltzing, O. Up-regulation of Kruppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. Mol. Cancer Res., 2009, 7(8), 1390-1398.
27. Sharma, V.; Shaheen, S.S.; Dixit, D.; Sen, E. Farnesyltransferase inhibitor manumycin targets IL1beta-Ras-HIF-1alpha axis in tumor cells of diverse origin. Inflammation, 2012, 35(2), 516-519.
28. Rider, P.; Carmi, Y.; Guttman, O.; Braiman, A.; Cohen, I.; Voronov, E.; White, M.R.; Dinarello, C.A.; Apte, R.N.; IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J. Immunol., 2011, 187(9), 4835-4843.
29. Tewari, R.; Choudhury, S.R.; Ghosh, S.; Mehta, V.S.; Sen, E. Involvement of TNFalpha-induced TLR4-NF-kappaB and TLR4-HIF-1alpha feed-forward loops in the regulation of inflammatory responses in glioma. J. Mol. Med. (Berl.)., 2012, 90(1), 67-80.
30. Liu, Y.; Han, Z.P.; Zhang, S.S.; Jing, Y.Y.; Bu, X.X.; Wang, C.Y.; Sun, K.; Jiang, G.C.; Zhao, X.; Li, R.; Gao, L.; Zhao, Q.D.; Wu, M.C.; Wei, L.X. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J. Biol. Chem., 2011, 286(28), 25007-25015.
31. Chuang, M.J.; Sun, K.H.; Tang, S.J.; Deng, M.W.; Wu, Y.H.; Sung, J.S.; Cha, T.L.; Sun, G.H. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci., 2008, 99(5), 905-913.
32. Hindryckx, P.; De Vos, M.; Jacques, P.; Ferdinande, L.; Peeters, H.; Olievier, K.; Bogaert, S.; Brinkman, B.; Vandenabeele, P.; Elewaut, D.; Laukens, D. Hydroxylase inhibition abrogates TNFalpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J. Immunol., 2010, 185(10), 6306-6316.
33. Liu, H.; Li, M.; Wang, P.; Wang, F. Blockade of hypoxia-inducible factor-1alpha by YC-1 attenuates interferon-gamma and tumor necrosis factor-alpha-induced intestinal epithelial barrier dysfunction. Cytokine, 2011, 56(3), 581-588.
34. Liu, H.; Wang, P.; Cao, M.; Li, M.; Wang, F. Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-gamma and TNF-alpha. Cell Physiol. Biochem., 2012, 29(5-6), 799-808.
35. Fitzpatrick, S.F.; Tambuwala, M.M.; Bruning, U.; Schaible, B.; Scholz, C.C.; Byrne, A.; O'Connor, A.; Gallagher, W.M.; Lenihan, C.R.; Garvey, J.F.; Howell, K.; Fallon, P.G.; Cummins, E.P.; Taylor, C.T. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia, J. Immunol., 2011, 186(2), 1091-1096.
36. Cummins, E.P.; Seeballuck, F.; Keely, S.J.; Mangan, N.E.; Callanan, J.J.; Fallon, P.G.; Taylor, C.T. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology, 2008, 134(1), 156-165.
37. Shah, Y.M.; Ito, S.; Morimura, K.; Chen, C.; Yim, S.H.; Haase, V.H.; Gonzalez, F.J.; Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology, 2008, 134(7), 2036-2048.
38. Fuertes, M.B.; Woo, S.R.; Burnett, B.; Fu, Y.X.; Gajewski, T.F. Type I interferon response and innate immune sensing of cancer. Trends Immunol., 2012. [Epub ahead of print].
39. Acosta-Iborra, B.; Elorza, A.; Olazabal, I.M.; Martin-Cofreces, N.B.; Martin-Puig, S.; Miro, M.; Calzada, M.J.; Aragones, J.; Sanchez-Madrid, F.; Landazuri, M.O. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J. Immunol., 2009, 182(5), 3155-3164.
40. Gerber, S.A.; Yatsula, B.; Maier, C.L.; Sadler, T.J.; Whittaker, L.W.; Pober, J.S. Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2009, 29(9), 1363-1369.
41. Howren, M.B.; Lamkin, D.M.; Suls, J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med., 2009, 71(2), 171-186.
42. Ryu, J.H.; Yang, S.; Shin, Y.; Rhee, J.; Chun, C.H.; Chun, J.S. Interleukin-6 plays an essential role in hypoxia-inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum., 2011, 63(9), 2732-2743.
43. Imtiyaz, H.Z.; Williams, E.P.; Hickey, M.M.; Patel, S.A.; Durham, A.C.; Yuan, L.J.; Hammond, R.; Gimotty, P.A.; Keith, B.; Simon, M.C. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest., 2010, 120(8), 2699-2714.
44. Lall, H.; Coughlan, K.; Sumbayev, V.V. HIF-1alpha protein is an essential factor for protection of myeloid cells against LPS-induced depletion of ATP and apoptosis that supports Toll-like receptor 4-mediated production of IL-6. Mol. Immunol., 2008, 45(11), 3045-3049.
45. Nicholas, S.A.; Coughlan, K.; Yasinska, I.; Lall, G.S.; Gibbs, B.F.; Calzolai, L.; Sumbayev, V.V. Dysfunctional mitochondria contain endogenous high-affinity human Toll-like receptor 4 (TLR4) ligands and induce TLR4-mediated inflammatory reactions. Int. J. Biochem. Cell Biol., 2011, 43(4), 674-681.
46. Wan, J.; Ma, J.; Mei, J.; Shan, G. The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells. J. Exp. Clin. Cancer Res., 2009, 28, 150.
47. Niu, G.; Briggs, J.; Deng, J.; Ma, Y.; Lee, H.; Kortylewski, M.; Kujawski, M.; Kay, H.; Cress, W.D.; Jove, R.; Yu, H. Signal transducer and activator of transcription 3 is required for hypoxiainducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol. Cancer Res., 2008, 6(7), 1099-1105.
48. Xu, Q.; Briggs, J.; Park, S.; Niu, G.; Kortylewski, M.; Zhang, S.; Gritsko, T.; Turkson, J.; Kay, H.; Semenza, G.L.; Cheng, J.Q.; Jove, R.; Yu, H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 2005, 24(36), 5552-5560.
49. Jiang, H.; Zhu, Y.S.; Xu, H.; Sun, Y.; Li, Q.F. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B. Am. J. Physiol. Lung Cell Mol. Physiol., 2010, 298(5), L660-669.
50. Yamaji-Kegan, K.; Su, Q.; Angelini, D.J.; Johns, R.A. IL-4 is proangiogenic in the lung under hypoxic conditions. J. Immunol., 2009, 182(9), 5469-5476.
51. Scharte, M.; Jurk, K.; Kehrel, B.; Zarbock, A.; Van Aken, H.; Singbartl, K. IL-4 enhances hypoxia induced HIF-1alpha protein levels in human transformed intestinal cells. FEBS Lett., 2006, 580(27), 6399-6404.
52. Tepper, R.I.; Pattengale, P.K.; Leder, P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 1989, 57(3), 503-512.
53. Post, D.E.; Sandberg, E.M.; Kyle, M.M.; Devi, N.S.; Brat, D.J.; Xu, Z.; Tighiouart, M.; Van Meir, E.G. Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4. Cancer Res., 2007, 67(14), 6872-6881.
54. Hot, A.; Zrioual, S.; Lenief, V.; Miossec, P. IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes. Ann. Rheum. Dis., 2012, 71(8), 1393-1401.
55. Ahn, J.K.; Koh, E.M.; Cha, H.S.; Lee, Y.S.; Kim, J.; Bae, E.K.; Ahn, K.S. Role of hypoxia-inducible factor-1alpha in hypoxiainduced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford), 2008, 47(6), 834-839.
56. Westra, J.; Brouwer, E.; van Roosmalen, I.A.; Doornbos-van der Meer, B.; van Leeuwen, M.A.; Posthumus, M.D.; Kallenberg, C.G. Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor. BMC Musculoskelet Disord., 2010, 11, 61.
57. Wysoczynski, M.; Shin, D.M.; Kucia, M.; Ratajczak, M.Z. Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications. Int. J. Cancer, 2010, 126(2), 371-381.
58. Natarajan, R.; Fisher, B.J.; Fowler, A.A., 3rd. Hypoxia inducible factor-1 modulates hemin-induced IL-8 secretion in microvascular endothelium, Microvasc. Res., 2007, 73(3), 163-172.
59. Kim, K.S.; Rajagopal, V.; Gonsalves, C.; Johnson, C.; Kalra, V.K. A novel role of hypoxia-inducible factor in cobalt chloride-and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J. Immunol., 2006, 177(10), 7211-7224.
60. Chiang, Y.Y. Hepatocyte growth factor induces hypoxia-related interleukin-8 expression in lung adenocarcinoma cells. Mol. Carcinog., 2009, 48(7), 662-670.
61. Merighi, S.; Benini, A.; Mirandola, P.; Gessi, S.; Varani, K.; Simioni, C.; Leung, E.; Maclennan, S.; Baraldi, P.G.; Borea, P.A. Caffeine inhibits adenosine-induced accumulation of hypoxiainducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol. Pharmacol., 2007, 72(2), 395-406.
62. Florczyk, U.; Czauderna, S.; Stachurska, A.; Tertil, M.; Nowak, W.; Kozakowska, M.; Poellinger, L.; Jozkowicz, A.; Loboda, A.; Dulak, J. Opposite effects of HIF-1alpha and HIF-2alpha on the regulation of IL-8 expression in endothelial cells. Free Radic. Biol. Med., 2011, 51(10), 1882-1892.
63. Derynck, R.; Akhurst, R.J.; Balmain, A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet., 2001, 29(2), 117-129.
64. McMahon, S.; Charbonneau, M.; Grandmont, S.; Richard, D.E.; Dubois, C.M. Transforming growth factor beta1 induces hypoxiainducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem., 2006, 281(34), 24171-24181.
65. Ameln, A.K.; Muschter, A.; Mamlouk, S.; Kalucka, J.; Prade, I.; Franke, K.; Rezaei, M.; Poitz, D.M.; Breier, G.; Wielockx, B. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFbeta. Cancer Res., 2011, 71(9), 3306-3316.
66. Dunn, L.K.; Mohammad, K.S.; Fournier, P.G.; McKenna, C.R.; Davis, H.W.; Niewolna, M.; Peng, X.H.; Chirgwin, J.M.; Guise, T.A. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One, 2009, 4(9), e6896.
67. Jeon, S.H.; Chae, B.C.; Kim, H.A.; Seo, G.Y.; Seo, D.W.; Chun, G.T.; Kim, N.S.; Yie, S.W.; Byeon, W.H.; Eom, S.H.; Ha, K.S.; Kim, Y.M.; Kim, P.H. Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J. Leukoc. Biol., 2007, 81(2), 557-566.
68. Wei, H.; Bedja, D.; Koitabashi, N.; Xing, D.; Chen, J.; Fox-Talbot, K.; Rouf, R.; Chen, S.; Steenbergen, C.; Harmon, J.W.; Dietz, H.C.; Gabrielson, K.L.; Kass, D.A.; Semenza, G.L. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc. Natl. Acad. Sci. USA, 2012, 109(14), E841-850.
69. Copple, B.L. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int., 2010, 30(5), 669-682.
70. Zhou, G.; Dada, L.A.; Wu, M.; Kelly, A.; Trejo, H.; Zhou, Q.; Varga, J.; Sznajder, J.I. Hypoxia-induced alveolar epithelialmesenchymal transition requires mitochondrial ROS and hypoxiainducible factor 1. Am. J. Physiol. Lung Cell Mol. Physiol., 2009, 297(6), L1120-1130.
71. Braun, S.; Bitton-Worms, K.; LeRoith, D. The link between the metabolic syndrome and cancer. Int. J. Biol. Sci., 2011, 7(7), 1003-1015.
72. Sartori-Cintra, A.R.; Mara, C.S.; Argolo, D.L.; Coimbra, I.B. Regulation of hypoxia-inducible factor-1alpha (HIF-1alpha) expression by interleukin-1beta (IL-1 beta), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes. Clinics (Sao Paulo), 2012, 67(1), 35-40.
73. Sutton, K.M.; Hayat, S.; Chau, N.M.; Cook, S.; Pouyssegur, J.; Ahmed, A.; Perusinghe, N.; Le Floch, R.; Yang, J.; Ashcroft, M. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene, 2007, 26(27), 3920-3929.
74. Yu, J.; Li, J.; Zhang, S.; Xu, X.; Zheng, M.; Jiang, G.; Li, F. IGF-1 induces hypoxia-inducible factor 1alpha-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells. Brain Res., 2012, 1430, 18-24.
75. Doronzo, G.; Russo, I.; Mattiello, L.; Riganti, C.; Anfossi, G.; Trovati, M. Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling. Diabetologia, 2006, 49(5), 1049-1063.
76. Treins, C.; Giorgetti-Peraldi, S.; Murdaca, J.; Monthouel-Kartmann, M.N.; Van Obberghen, E. Regulation of hypoxiainducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol. Endocrinol., 2005, 19(5), 1304-1317.
77. Demidenko, Z.N.; Blagosklonny, M.V. The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1alpha. Cell Cycle, 2011, 10(10), 1557-1562.
78. Biswas, S.; Gupta, M.K.; Chattopadhyay, D.; Mukhopadhyay, C.K. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol., 2007, 292(2), H758-766.
79. Zhou, Q.; Liu, L.Z.; Fu, B.; Hu, X.; Shi, X.; Fang, J.; Jiang, B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis, 2007, 28(1), 28-37.
80. Gariboldi, M.B.; Ravizza, R.; Monti, E. The IGFR1 inhibitor NVPAEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells. Biochem. Pharmacol., 2010, 80(4), 455-462.
81. Carroll, V.A.; Ashcroft, M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res., 2006, 66(12), 6264-6270.
82. Catrina, S.B.; Botusan, I.R.; Rantanen, A.; Catrina, A.I.; Pyakurel, P.; Savu, O.; Axelson, M.; Biberfeld, P.; Poellinger, L.; Brismar, K. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulinlike growth factor-I. Clin. Cancer Res., 2006, 12(15), 4506-4514.
83. Fadini, G.P.; Sartore, S.; Schiavon, M.; Albiero, M.; Baesso, I.; Cabrelle, A.; Agostini, C.; Avogaro, A. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia, 2006, 49(12), 3075-3084.
84. Thangarajah, H.; Yao, D.; Chang, E.I.; Shi, Y.; Jazayeri, L.; Vial, I.N.; Galiano, R.D.; Du, X.L.; Grogan, R.; Galvez, M.G.; Januszyk, M.; Brownlee, M.; Gurtner, G.C. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc. Natl. Acad. Sci. USA, 2009, 106(32), 13505-13510.
85. Bento, C.F.; Fernandes, R.; Ramalho, J.; Marques, C.; Shang, F.; Taylor, A.; Pereira, P. The chaperone-dependent ubiquitin ligase CHIP targets HIF-1alpha for degradation in the presence of methylglyoxal. PLoS ONE, 2010, 5(11), e15062.
86. Lu, D.; Zhang, L.; Wang, H.; Zhang, Y.; Liu, J.; Xu, J.; Liang, Z.; Deng, W.; Jiang, Y.; Wu, Q.; Li, S.; Ai, Z.; Zhong, Y.; Ying, Y.; Liu, H.; Gao, F.; Zhang, Z.; Chen, B. Peroxisome proliferatoractivated receptor-gamma coactivator-1alpha (PGC-1alpha) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia. Diabetes, 2012, 61(5), 1153-1159.
87. Sarkar, K.; Fox-Talbot, K.; Steenbergen, C.; Bosch-Marce, M.; Semenza, G.L. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc. Natl. Acad. Sci. USA, 2009, 106(44), 18769-18774.
88. Kajiwara, H.; Luo, Z.; Belanger, A.J.; Urabe, A.; Vincent, K.A.; Akita, G.Y.; Cheng, S.H.; Mochizuki, S.; Gregory, R.J.; Jiang, C. A hypoxic inducible factor-1 alpha hybrid enhances collateral development and reduces vascular leakage in diabetic rats. J. Gene Med., 2009, 11(5), 390-400.
89. Albina, J.E.; Mastrofrancesco, B.; Vessella, J.A.; Louis, C.A.; Henry, W.L., Jr.; Reichner, J.S. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am. J. Physiol. Cell Physiol., 2001, 281(6), C1971-1977.
90. Yu, D.H.; Mace, K.A.; Hansen, S.L.; Boudreau, N.; Young, D.M. Effects of decreased insulin-like growth factor-1 stimulation on hypoxia inducible factor 1-alpha protein synthesis and function during cutaneous repair in diabetic mice. Wound Repair Regen., 2007, 15(5), 628-635.
91. Mace, K.A.; Yu, D.H.; Paydar, K.Z.; Boudreau, N.; Young, D.M. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen., 2007, 15(5), 636-645.
92. Botusan, I.R.; Gupta Sunkari, V.; Savu, O.; Catrina, A.I.; Grunler, J.; Lindberg, S.; Pereira, T.; Yla-Herttuala, S.; Poellinger, L.; Brismar, K.; Catrina, S.B. Stabilization of HIF-1{alpha} is critical to improve wound healing in diabetic mice. Proc. Natl. Acad. Sci. USA, 2008, 105(49), 19426-19431.
93. Borkow, G.; Gabbay, J.; Dardik, R.; Eidelman, A.I.; Lavie, Y.; Grunfeld, Y.; Ikher, S.; Huszar, M.; Zatcoff, R.C.; Marikovsky, M. Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings. Wound Repair Regen., 2010, 18(2), 266-275.
94. Wetterau, M.; George, F.; Weinstein, A.; Nguyen, P.D.; Tutela, J.P.; Knobel, D.; Cohen Ba, O.; Warren, S.M.; Saadeh, P.B. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure. Wound Repair Regen. 2011, 19(4), 481-486.
95. Marfella, R.; Esposito, K.; Nappo, F.; Siniscalchi, M.; Sasso, F.C.; Portoghese, M.; Di Marino, M.P.; Baldi, A.; Cuzzocrea, S.; Di Filippo, C.; Barboso, G.; Baldi, F.; Rossi, F.; D'Amico, M.; Giugliano, D. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes, 2004, 53(9), 2383-2391.
96. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
97. Berger, A.P.; Kofler, K.; Bektic, J.; Rogatsch, H.; Steiner, H.; Bartsch, G.; Klocker, H. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate, 2003, 57(1), 57-65.
98. Liu, L.Z.; Hu, X.W.; Xia, C.; He, J.; Zhou, Q.; Shi, X.; Fang, J.; Jiang, B.H. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxiainducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med., 2006, 41(10), 1521-1533.
99. Nilsson, M.B.; Zage, P.E.; Zeng, L.; Xu, L.; Cascone, T.; Wu, H.K.; Saigal, B.; Zweidler-McKay, P.A.; Heymach, J.V. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene, 2010, 29(20), 2938-2949.
100. Nakamura, K.; Martin, K.C.; Jackson, J.K.; Beppu, K.; Woo, C.W.; Thiele, C.J. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxiainducible factor-1alpha in neuroblastoma cells. Cancer Res., 2006, 66(8), 4249-4255.
101. Peng, X.H.; Karna, P.; Cao, Z.; Jiang, B.H.; Zhou, M.; Yang, L. Cross-talk between epidermal growth factor receptor and hypoxiainducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J. Biol. Chem., 2006, 281(36), 25903-25914.
102. Tanaka, H.; Yamamoto, M.; Hashimoto, N.; Miyakoshi, M.; Tamakawa, S.; Yoshie, M.; Tokusashi, Y.; Yokoyama, K.; Yaginuma, Y.; Ogawa, K. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res., 2006, 66(23), 11263-11270.
103. Shi, Y.H.; Bingle, L.; Gong, L.H.; Wang, Y.X.; Corke, K.P.; Fang, W.G. Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology, 2007, 39(4), 396-400.
104. ten Freyhaus, H.; Dagnell, M.; Leuchs, M.; Vantler, M.; Berghausen, E.M.; Caglayan, E.; Weissmann, N.; Dahal, B.K.; Schermuly, R.T.; Ostman, A.; Kappert, K.; Rosenkranz, S. Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am. J. Respir. Crit. Care Med., 2011, 183(8), 1092-1102.
105. Lim, J.H.; Jung, C.R.; Lee, C.H.; Im, D.S. Egr-1 and serum response factor are involved in growth factors-and serum-mediated induction of E2-EPF UCP expression that regulates the VHL-HIF pathway. J. Cell Biochem., 2008, 105(4), 1117-1127.
106. Ampofo, E.; Kietzmann, T.; Zimmer, A.; Jakupovic, M.; Montenarh, M.; Gotz, C. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Int. J. Biochem. Cell Biol., 2010, 42(10), 1729-1735.
107. Paatero, I.; Jokilammi, A.; Heikkinen, P.T.; Iljin, K.; Kallioniemi, O.P.; Jones, F.E.; Jaakkola, P.M.; Elenius, K. Interaction with ErbB4 promotes hypoxia-inducible factor-1alpha signaling. J. Biol. Chem., 2012, 287(13), 9659-9671.
108. Hoffmann, A.C.; Mori, R.; Vallbohmer, D.; Brabender, J.; Klein, E.; Drebber, U.; Baldus, S.E.; Cooc, J.; Azuma, M.; Metzger, R.; Hoelscher, A.H.; Danenberg, K.D.; Prenzel, K.L.; Danenberg, P.V. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia, 2008, 10(7), 674-679.
109. Bhatt, R.S.; Landis, D.M.; Zimmer, M.; Torregrossa, J.; Chen, S.; Sukhatme, V.P.; Iliopoulos, O.; Balk, S.; Bubley, G.J. Hypoxiainducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor. BJU Int., 2008, 102(3), 358-363.
110. Minakata, K.; Takahashi, F.; Nara, T.; Hashimoto, M.; Tajima, K.; Murakami, A.; Nurwidya, F.; Yae, S.; Koizumi, F.; Moriyama, H.; Seyama, K.; Nishio, K.; Takahashi, K. Hypoxia Induces Gefitinib Resistance in Non-Small Cell Lung Cancer with Both Mutant and Wild-type Epidermal Growth Factor Receptors. Cancer Sci., 2012, 103(11), 1946-1954.
111. Leek, R.D.; Stratford, I.; Harris, A.L. The role of hypoxia-inducible factor-1 in three-dimensional tumor growth, apoptosis, and regulation by the insulin-signaling pathway. Cancer Res., 2005, 65(10), 4147-4152.
112. Iqbal, S.; Zhang, S.; Driss, A.; Liu, Z.R.; Kim, H.R.; Wang, Y.; Ritenour, C.; Zhau, H.E.; Kucuk, O.; Chung, L.W.; Wu, D. PDGF upregulates Mcl-1 through activation of beta-catenin and HIF-1alpha-dependent signaling in human prostate cancer cells. PLoS One, 2012, 7(1), e30764.
113. Lau, C.K.; Yang, Z.F.; Ho, D.W.; Ng, M.N.; Yeoh, G.C.; Poon, R.T.; Fan, S.T. An Akt/hypoxia-inducible factor-1alpha/plateletderived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin. Cancer Res., 2009, 15(10), 3462-3471.
114. Semenza, G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci., 2012, 33(4), 207-214.
115. Wang, Y.; Roche, O.; Xu, C.; Moriyama, E.H.; Heir, P.; Chung, J.; Roos, F.C.; Chen, Y.; Finak, G.; Milosevic, M.; Wilson, B.C.; Teh, B.T.; Park, M.; Irwin, M.S.; Ohh, M. Hypoxia promotes ligandindependent EGF receptor signaling via hypoxia-inducible factormediated upregulation of caveolin-1. Proc. Natl. Acad. Sci. USA, 2012, 109(13), 4892-4897.
116. Mardilovich, K.; Shaw, L.M. Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion. Cancer Res., 2009, 69(23), 8894-8901.
117. Karar, J.; Cerniglia, G.J.; Lindsten, T.; Koumenis, C.; Maity, A. Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxiainducible factor (HIF)-1alpha expression by blocking protein translation and increases cell death under hypoxia. Cancer Biol. Ther., 2012, 13(11), 1102-1111.
118. Medici, D.; Olsen, B.R. Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF. PLoS One, 2012, 7(8), e42913.
119. Spirli, C.; Okolicsanyi, S.; Fiorotto, R.; Fabris, L.; Cadamuro, M.; Lecchi, S.; Tian, X.; Somlo, S.; Strazzabosco, M. Mammalian target of rapamycin regulates vascular endothelial growth factordependent liver cyst growth in polycystin-2-defective mice. Hepatology, 2010, 51(5), 1778-1788.
120. Befani, C.D.; Vlachostergios, P.J.; Hatzidaki, E.; Patrikidou, A.; Bonanou, S.; Simos, G.; Papandreou, C.N.; Liakos, P. Bortezomib represses HIF-1alpha protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells. J. Mol. Med. (Berl.), 2012, 90(1), 45-54.
121. Lu, H.; Liang, K.; Lu, Y.; Fan, Z. The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1alpha. Cancer Lett., 2012, 322(1), 78-85.
122. Kimura, Y.; Inoue, K.; Abe, M.; Nearman, J.; Baranowska-Kortylewicz, J. PDGFRbeta and HIF-1alpha inhibition with imatinib and radioimmunotherapy of experimental prostate cancer. Cancer Biol. Ther., 2007, 6(11), 1763-1772.